Published in Biochemistry on October 02, 2014
Exploration of gated ligand binding recognizes an allosteric site for blocking FABP4-protein interaction. Phys Chem Chem Phys (2015) 0.75
The Amber biomolecular simulation programs. J Comput Chem (2005) 28.84
Development and testing of a general amber force field. J Comput Chem (2004) 23.29
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem (2003) 15.88
The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol (2009) 7.36
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 6.15
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov (2008) 5.78
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature (2007) 4.59
Long-timescale molecular dynamics simulations of protein structure and function. Curr Opin Struct Biol (2009) 3.81
Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol (2002) 2.58
New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci (2002) 2.18
Ligand binding alters the backbone mobility of intestinal fatty acid-binding protein as monitored by 15N NMR relaxation and 1H exchange. Biochemistry (1997) 1.72
Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4. Biochemistry (2007) 1.58
Structural and functional analysis of fatty acid-binding proteins. J Lipid Res (2008) 1.56
Structural basis for activation of fatty acid-binding protein 4. J Mol Biol (2007) 1.52
Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry (2000) 1.39
Studies of the ligand binding reaction of adipocyte lipid binding protein using the fluorescent probe 1, 8-anilinonaphthalene-8-sulfonate. Biophys J (1999) 1.37
Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins. J Med Chem (2009) 1.32
The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids. J Biol Chem (1993) 1.31
Insights into binding of fatty acids by fatty acid binding proteins. Mol Cell Biochem (2002) 1.29
Latest developments in molecular docking: 2010-2011 in review. J Mol Recognit (2013) 1.26
Coupling of receptor conformation and ligand orientation determine graded activity. Nat Chem Biol (2010) 1.25
Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. Structure (2012) 1.21
Solution-state molecular structure of apo and oleate-liganded liver fatty acid-binding protein. Biochemistry (2007) 1.18
Kinetics of fatty acid interactions with fatty acid binding proteins from adipocyte, heart, and intestine. J Biol Chem (1996) 1.15
Adipocyte lipid-binding protein complexed with arachidonic acid. Titration calorimetry and X-ray crystallographic studies. J Biol Chem (1994) 1.14
Backbone and side chain dynamics of uncomplexed human adipocyte and muscle fatty acid-binding proteins. Biochemistry (1998) 1.07
Crystal structure of recombinant murine adipocyte lipid-binding protein. Biochemistry (1992) 1.05
Biochemical and crystallographic analyses of a portal mutant of the adipocyte lipid-binding protein. J Biol Chem (1997) 1.01
Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors. J Chem Theory Comput (2013) 0.99
Solution structure and backbone dynamics of human epidermal-type fatty acid-binding protein (E-FABP). Biochem J (2002) 0.98
Modulation of ligand binding affinity of the adipocyte lipid-binding protein by selective mutation. Analysis in vitro and in situ. J Biol Chem (1993) 0.98
Agonist dynamics and conformational selection during microsecond simulations of the A(2A) adenosine receptor. Biophys J (2012) 0.96
Ligand-binding dynamics rewire cellular signaling via estrogen receptor-α. Nat Chem Biol (2013) 0.96
Testing of the portal hypothesis: analysis of a V32G, F57G, K58G mutant of the fatty acid binding protein of the murine adipocyte. Biochemistry (2002) 0.95
ALiBERO: evolving a team of complementary pocket conformations rather than a single leader. J Chem Inf Model (2012) 0.94
Predictive power of molecular dynamics receptor structures in virtual screening. J Chem Inf Model (2011) 0.93
Structure and backbone dynamics of Apo- and holo-cellular retinol-binding protein in solution. J Biol Chem (2002) 0.89
Molecular dynamics simulation of ligand dissociation from liver fatty acid binding protein. PLoS One (2009) 0.89
Conformational transition and energy landscape of ErbB4 activated by neuregulin1β: one microsecond molecular dynamics simulations. J Am Chem Soc (2012) 0.88
Simulations of fatty acid-binding proteins. II. Sites for discrimination of monounsaturated ligands. Biophys J (1998) 0.88
Binding of retinol induces changes in rat cellular retinol-binding protein II conformation and backbone dynamics. J Mol Biol (2000) 0.88
Simulations of fatty acid-binding proteins suggest sites important for function. I. Stearic acid. Biophys J (1998) 0.87
Molecular dynamics simulations of palmitate entry into the hydrophobic pocket of the fatty acid binding protein. FEBS Lett (2007) 0.86
Fatty acid binding proteins: same structure but different binding mechanisms? Molecular dynamics simulations of intestinal fatty acid binding protein. Biophys J (2005) 0.86
Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations. PLoS Comput Biol (2013) 0.85
Molecular dynamics simulations of the adipocyte lipid binding protein reveal a novel entry site for the ligand. Biochemistry (2005) 0.85
Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example. J Chem Inf Model (2012) 0.84
Analysis of a series of phenylalanine 57 mutants of the adipocyte lipid-binding protein. Biochemistry (1998) 0.84
Fatty acid interactions with native and mutant fatty acid binding proteins. Mol Cell Biochem (1999) 0.84
Molecular dynamics simulations of adipocyte lipid-binding protein: effect of electrostatics and acyl chain unsaturation. Biochemistry (1996) 0.83
Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures. J Chem Inf Model (2011) 0.83
Conformational dynamics of full-length inducible human Hsp70 derived from microsecond molecular dynamics simulations in explicit solvent. J Biomol Struct Dyn (2012) 0.78
Investigating the mutation resistance of nonnucleoside inhibitors of HIV-RT using multiple microsecond atomistic simulations. Proteins (2013) 0.78
Molecular dynamics study of the interaction between fatty acid binding proteins with palmitate mini-micelles. Mol Cell Biochem (2009) 0.76
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci U S A (2007) 7.96
Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer (2004) 6.67
Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell (2006) 3.62
Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation. Science (2012) 2.50
Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem (2003) 2.30
Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci U S A (2010) 2.16
Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE (2003) 2.12
Organization of the core structure of the postsynaptic density. Proc Natl Acad Sci U S A (2008) 2.06
The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol (2009) 1.99
Development of genome-wide DNA polymorphism database for map-based cloning of rice genes. Plant Physiol (2004) 1.98
Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (2002) 1.77
The functional contrariety of JNK. Mol Carcinog (2007) 1.77
Genomic evidence for ameiotic evolution in the bdelloid rotifer Adineta vaga. Nature (2013) 1.76
Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Cancer Res (2006) 1.76
How human location-specific contact patterns impact spatial transmission between populations? Sci Rep (2013) 1.74
Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell (2008) 1.71
Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer (2011) 1.69
Light-induced rescue of breathing after spinal cord injury. J Neurosci (2008) 1.68
KNN/BNT composite lead-free films for high-frequency ultrasonic transducer applications. IEEE Trans Ultrason Ferroelectr Freq Control (2011) 1.65
Evolution of scaling emergence in large-scale spatial epidemic spreading. PLoS One (2011) 1.64
Prevalence of and racial differences in pterygium: a multiethnic population study in Asians. Ophthalmology (2012) 1.63
Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res (2008) 1.62
NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int (2013) 1.61
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res (2006) 1.60
Congenital lethal motor neuron disease with a novel defect in ribosome biogenesis. Neurology (2014) 1.59
Development of integrated preamplifier for high-frequency ultrasonic transducers and low-power handheld receiver. IEEE Trans Ultrason Ferroelectr Freq Control (2011) 1.58
Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat (2009) 1.56
Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics (2014) 1.55
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology (2007) 1.51
Ceramide-enriched membrane domains--structure and function. Biochim Biophys Acta (2008) 1.49
Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells. Stem Cells (2010) 1.48
Integrated intravascular optical coherence tomography ultrasound imaging system. J Biomed Opt (2010) 1.47
Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis (2010) 1.47
Subcellular organelle lipidomics in TLR-4-activated macrophages. J Lipid Res (2010) 1.46
Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem J (2006) 1.46
Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. Mol Biol Cell (2005) 1.45
The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett (2006) 1.43
Identification of a hybrid PKS/NRPS required for pseurotin A biosynthesis in the human pathogen Aspergillus fumigatus. Chembiochem (2007) 1.42
Photocatalytic oxidation of arsenite over TiO2: is superoxide the main oxidant in normal air-saturated aqueous solutions? Environ Sci Technol (2011) 1.42
Patient-specific dose estimation for pediatric chest CT. Med Phys (2008) 1.41
Rapid detection of the ACMG/ACOG-recommended 23 CFTR disease-causing mutations using ion torrent semiconductor sequencing. J Biomol Tech (2012) 1.40
MicroRNAome of porcine pre- and postnatal development. PLoS One (2010) 1.40
The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol (2002) 1.37
Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Int J Urol (2007) 1.36
Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog (2013) 1.36
Integrated optical coherence tomography, ultrasound and photoacoustic imaging for ovarian tissue characterization. Biomed Opt Express (2011) 1.35
Reduction of false positives by internal features for polyp detection in CT-based virtual colonoscopy. Med Phys (2005) 1.34
The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J Biol Chem (2005) 1.34
Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cancer Res (2007) 1.33
Nitrogen-doped porous carbon nanofiber webs as anodes for lithium ion batteries with a superhigh capacity and rate capability. Adv Mater (2012) 1.33
PSD-95 is required to sustain the molecular organization of the postsynaptic density. J Neurosci (2011) 1.33
High-resolution coregistered intravascular imaging with integrated ultrasound and optical coherence tomography probe. Appl Phys Lett (2010) 1.32
Gold biomineralization by a metallophore from a gold-associated microbe. Nat Chem Biol (2013) 1.31
Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension (2012) 1.31
ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nat Struct Mol Biol (2012) 1.30
Isolation and characterization of a new ginsenoside from the fresh root of Panax Ginseng. Molecules (2010) 1.30
Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res (2008) 1.30
miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. Mol Cancer Ther (2012) 1.29
Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res (2008) 1.29
An improved electronic colon cleansing method for detection of colonic polyps by virtual colonoscopy. IEEE Trans Biomed Eng (2006) 1.28
Roles of mixing patterns in cooperation on a scale-free networked game. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 1.27
Identification and characterization of PWWP domain residues critical for LEDGF/p75 chromatin binding and human immunodeficiency virus type 1 infectivity. J Virol (2008) 1.27
Tpl2 is a key mediator of arsenite-induced signal transduction. Cancer Res (2009) 1.26
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res (2009) 1.26
Inducible covalent posttranslational modification of histone H3. Sci STKE (2005) 1.26
Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus. J Biol Chem (2008) 1.26
Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol (2008) 1.26
NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res (2002) 1.25
Novel combined miniature optical coherence tomography ultrasound probe for in vivo intravascular imaging. J Biomed Opt (2011) 1.25
miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol Cancer Ther (2013) 1.23
MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS One (2013) 1.23
Integrated ultrasound and photoacoustic probe for co-registered intravascular imaging. J Biomed Opt (2011) 1.20
Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res (2008) 1.20
Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation. Cancer Res (2005) 1.20
Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res (2003) 1.20
Six cytotoxic annonaceous acetogenins from Annona squamosa seeds. Food Chem (2012) 1.19
Mortality and morbidity associated with simultaneous bilateral or staged bilateral total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg (2011) 1.19
RSK2 mediates muscle cell differentiation through regulation of NFAT3. J Biol Chem (2007) 1.19
HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor. Nucleic Acids Res (2012) 1.18
Pim kinase substrate identification and specificity. J Biochem (2007) 1.17
Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog (2008) 1.17
Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection. J Immunol (2010) 1.17
p85alpha acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiation. Mol Cell Biol (2007) 1.15
Repression of seed maturation genes by a trihelix transcriptional repressor in Arabidopsis seedlings. Plant Cell (2009) 1.15
Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. J Ethnopharmacol (2012) 1.15
Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev (2007) 1.14
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells. Breast Cancer Res (2008) 1.14
Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer. Mol Cancer Ther (2011) 1.14
Regulation of microRNAs by epigenetics and their interplay involved in cancer. J Exp Clin Cancer Res (2013) 1.14
Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. Am J Physiol Heart Circ Physiol (2010) 1.13
Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1. J Biol Chem (2007) 1.13
The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory. Nat Neurosci (2011) 1.13
Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol (2003) 1.12
Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties. J Cancer Res Clin Oncol (2012) 1.12
Cancer prevention research - then and now. Nat Rev Cancer (2009) 1.12
The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity. Nat Struct Mol Biol (2005) 1.12
Pediatric chest and abdominopelvic CT: organ dose estimation based on 42 patient models. Radiology (2013) 1.12
Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis (2007) 1.11
Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation. J Biol Chem (2002) 1.10